AI-generated summary
In this laboratory study, the authors tested low-level laser therapy combined with toluidine blue on Streptococcus mutans biofilms grown on acrylic blocks. The treatment reduced viable bacteria in a dose-dependent manner, performing comparably to chlorhexidine in inhibiting bacterial growth, and the authors report that polysaccharide concentrations were not significantly different from chlorhexidine.
- Who or what was studied
- Streptococcus mutans biofilms grown on acrylic resin blocks (in vitro study; no human participants)
- Limits stated in the abstract
- The study was performed in vitro on bacterial biofilms, so the findings may not apply to human oral tissue, and the abstract reports no participant numbers.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Photodynamic therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.